2018
DOI: 10.5603/ait.2018.0004
|View full text |Cite
|
Sign up to set email alerts
|

The impact of the blood glucose levels of non-diabetic critically ill patients on their clinical outcome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 9 publications
0
4
0
Order By: Relevance
“…Cytokine release as a consequence of severe infection may precipitate the onset of metabolic alterations by affecting glucose homeostasis, which lead to abnormalities in glycometabolic control, insulin resistance and beta cell dysfunction in patients with infection without any pre-existing history or diagnosis of diabetes. Stress hyperglycaemia seriously affects the stability of the body's internal environment, which cause a profound impact on metabolism and immune function, thereby affecting the patients' prognosis [4,5]. Stress hyperglycaemia is associated with an increased risk of in-hospital mortality regardless of whether the patients have diabetes background or not [1,6].…”
Section: / 25mentioning
confidence: 99%
“…Cytokine release as a consequence of severe infection may precipitate the onset of metabolic alterations by affecting glucose homeostasis, which lead to abnormalities in glycometabolic control, insulin resistance and beta cell dysfunction in patients with infection without any pre-existing history or diagnosis of diabetes. Stress hyperglycaemia seriously affects the stability of the body's internal environment, which cause a profound impact on metabolism and immune function, thereby affecting the patients' prognosis [4,5]. Stress hyperglycaemia is associated with an increased risk of in-hospital mortality regardless of whether the patients have diabetes background or not [1,6].…”
Section: / 25mentioning
confidence: 99%
“…Stress hyperglycaemia seriously affects the stability of the body's internal environment, which cause a profound impact on metabolism and immune function, thereby affecting the patients' prognosis. 2,8 Stress hyperglycaemia is associated with an increased risk of in-hospital mortality regardless of whether the patients have diabetes background or not. 1,9 It is suggested that COVID-19-associated newonset hyperglycaemia may predispose patients to longterm hyperglycaemia, worse clinical outcomes and clinical scores, prolonged hospital stays higher demand for oxygen support or positive-pressure ventilation.…”
Section: Introductionmentioning
confidence: 99%
“…Cytokine release as a consequence of severe infection may precipitate the onset of metabolic alterations by affecting glucose homeostasis, which leads to abnormalities in glycometabolic control, insulin resistance (IR) and β cell dysfunction in patients with infection even without any pre‐existing history or diagnosis of diabetes. Stress hyperglycaemia seriously affects the stability of the body's internal environment, which cause a profound impact on metabolism and immune function, thereby affecting the patients’ prognosis 2,8 . Stress hyperglycaemia is associated with an increased risk of in‐hospital mortality regardless of whether the patients have diabetes background or not 1,9 .…”
Section: Introductionmentioning
confidence: 99%
“…Insulin resistance may lead to hyperglycemia and decreased tissue responsiveness to the biological activity of insulin, a metabolic problem that induces catabolic state and may lead to increased morbidity, prolonged hospital and intensive care unit (ICU) stay and decreased survival [ 2 , 3 , 4 , 5 ]. Stress hyperglycemia, even in non-diabetic patients, is a marker of stress response in critically ill patients and results from a release of contra-insulin hormones (i.e., glucocorticoids and catecholamines) [ 6 ]. Hyperglycemia after cardiac surgery can be detrimental to the heart due to glucose toxicity that causes increased oxidative stress via the hexosamine metabolic pathway and by elevated levels of advanced glycation end-products [ 7 , 8 , 9 ].…”
Section: Introductionmentioning
confidence: 99%